0A88 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - 10X Genomics Inc

Watchlist Manager

Watchlist

Price: 92.07 USD 3.69%

Market Cap: $11.7B

	10X Genomics Inc LSE:0A88	US
	Rio Tinto PLC LSE:RIO	UK
I	Imperial Brands PLC DUS:ITB	UK
	Mitsui & Co Ltd TSE:8031	JP
C	Coca-Cola Co XMUN:CCC3	US
V	Veeva Systems Inc LSE:0LO3	US
	Dabur India Ltd NSE:DABUR	IN
U	UniCredit SpA SWB:CRIN	IT
B	Barclays PLC SWB:BCY	UK
T	Thales SA OTC:THLEF	FR
	Shoprite Holdings Ltd F:HY7A	ZA
U	US Bancorp DUS:UB5	US
N	NEC Corp SWB:NEC1	JP
S	Sempra DUS:SE4	US

Profitability Summary

10X Genomics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

70%

Strong 3Y Average Gross Margin

68%

Declining Gross Margin

70% > 70%

Negative Operating Margin

-14%

Negative 3Y Average Operating Margin

-27%

Operating Margin is Increasing

-39% > -14%

Negative Net Margin

-12%

Negative 3Y Average Net Margin

-24%

Net Margin is Increasing

-38% > -12%

Exceptional Free Cash Flow Margin

20%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-19% > 20%

Negative ROE

-9%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-33%

ROIC is Increasing

-44% > -18%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.